Symple Surgical Awarded SBIR Phase I Grant for Novel Radiometry‐Guided Ablation Catheter to Reliably Treat Barrett's Esophagus
February 01, 2022 09:00 ET
|
Symple Surgical
FLAGSTAFF, Ariz., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Symple Surgical Inc. (SSI) announced today that it has received a Small Business Innovation Research (SBIR) Phase I grant award totaling...
Cernostics Contracts with Geisinger Health Plan to Become an In-network Provider for TissueCypher® Barrett’s Esophagus Assay
September 08, 2021 09:00 ET
|
Cernostics
Pittsburgh, PA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Cernostics, pioneer of the worlds’ first precision medicine test to predict future development risk of esophageal cancer from Barrett’s esophagus...
Aqua Medical Announces First-in-Human Experience of RF Vapor Ablation Therapy for Barrett's Esophagus Published in Endoscopy
March 11, 2021 11:00 ET
|
Aqua Medical
Santa Ana, CA, March 11, 2021 (GLOBE NEWSWIRE) -- Aqua Medical, developer of the FDA 510(k)-cleared vapor-based endoscopic ablation technology for gastrointestinal disease and GI cancer prevention,...